Article
Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment
25 May 2018
Abstract excerpt
This study enumerated patients' preference-based personal utility and willingness-to-pay for massively parallel sequencing (MPS) genetic testing of colorectal cancer (CRC) risk. Our setting was the New Exome Technology in (NEXT) Medicine Study, a randomized control trial of usual care genetic testing vs. exome sequencing. Using a discrete choice experiment (DCE), we elicited patient preferences for information on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
